15% of all platelets distributed to U.S. hospitals (~398,000 units/year) are never transfused because their 5-day shelf life expires before use

Platelets have the shortest shelf life of any blood component — just 5 days from collection. Unlike red blood cells (42-day shelf life) or frozen plasma (up to a year), platelets must be stored at room temperature on a continuous agitator and cannot be frozen for routine use. This creates an impossible inventory management problem: hospitals must keep platelets on hand for emergencies (trauma, surgical bleeding, cancer patients with critically low counts), but the moment they receive a shipment, a 5-day countdown begins. In 2023, approximately 398,000 platelet units distributed to U.S. hospitals were never transfused — a 15% waste rate. The waste is not merely financial, though each platelet unit costs $500-$600 to collect, test, and process. Each wasted unit represents a donor who sat in an apheresis chair for 90-120 minutes to donate platelets specifically. The real patient impact is that hospitals, knowing platelets expire quickly, tend to either over-order (causing waste) or under-order (causing shortages). During the August 2024 blood shortage, platelets were among the most critically needed products, and some hospitals had to delay chemotherapy infusions and postpone surgeries because they could not secure enough platelets — even while other hospitals in the same region were discarding expired units. The structural reason this waste persists is that there is no real-time inter-hospital redistribution system for near-expiration platelets. A hospital in suburban New Jersey with two expiring platelet units tomorrow has no efficient way to identify and ship those units to a hospital in the Bronx that needs them today. Each hospital orders independently from its blood supplier, and leftover inventory expires in isolation. A 2024 study in the journal Transfusion demonstrated that inter-hospital redistribution programs can significantly reduce outdating, but most U.S. regions have no such program in place because the logistics of same-day cold-chain transport, liability for product quality during transfer, and the administrative overhead of inter-hospital billing make it easier to just throw the platelets away.